135 related articles for article (PubMed ID: 51887)
1. Immune response to a syngeneic mammary adenocarcinoma. II. In vitro generation of cytotoxic lymphocytes.
Kuperman O; Fortner GW; Lucas ZJ
J Immunol; 1975 Nov; 115(5):1277-81. PubMed ID: 51887
[TBL] [Abstract][Full Text] [Related]
2. Immune response to a syngeneic mammary adenocarcinoma. III. Development of memory and suppressor functions modulating cellular cytotoxicity.
Kuperman O; Fortner GW; Lucas ZJ
J Immunol; 1975 Nov; 115(5):1282-7. PubMed ID: 1176776
[TBL] [Abstract][Full Text] [Related]
3. Immune response to a syngeneic mammary adenocarcinoma. I. Comparison of kinetics of tumor cell growth and cytotoxic responses in syngeneic and allogeneic rats.
Fortner GW; Kuperman O; Lucas ZJ
J Immunol; 1975 Nov; 115(5):1269-76. PubMed ID: 1080776
[TBL] [Abstract][Full Text] [Related]
4. Tumor-specific suppressor cells induced by immunization with spleen cells from tumor-bearing animals.
Huber SA; Bigi G; Lucas ZJ
Cancer Res; 1980 Oct; 40(10):3477-83. PubMed ID: 6449281
[TBL] [Abstract][Full Text] [Related]
5. Immune response to a mammary adenocarcinoma. V. Sera from tumor-bearing rats contain multiple factors blocking cell-mediated cytotoxicity.
Huber SA; Lucas ZJ
J Immunol; 1978 Dec; 121(6):2485-9. PubMed ID: 722081
[TBL] [Abstract][Full Text] [Related]
6. Differences in kinetic parameters of lysis by syngeneic and allogeneic T lymphocytes immune to the same tumor.
Huber SA; Lucas ZJ
J Immunol; 1978 Dec; 121(6):2270-7. PubMed ID: 309897
[No Abstract] [Full Text] [Related]
7. Immune response to a mammary adenocarcinoma. VI. Blocking of tumor-specific cell-mediated cytotoxicity by antibodies to the cytotoxic lymphocyte.
Huber SA; Lucas ZJ
J Immunol; 1978 Dec; 121(6):2490-6. PubMed ID: 309904
[No Abstract] [Full Text] [Related]
8. Characterization of the effector cells mediating an "innocent bystander" cytotoxicity reaction induced by a syngeneic mammary adenocarcinoma in mice.
Paul RD; Padmanabhan R; Lopez DM
Cancer Res; 1984 Oct; 44(10):4480-6. PubMed ID: 6467207
[TBL] [Abstract][Full Text] [Related]
9. Effects of sodium periodate modification of lymphocytes on the sensitization and lytic phases of T cell-mediated lympholysis.
Schmitt-Verhulst A; Shearer GM
J Immunol; 1976 Apr; 116(4):947-58. PubMed ID: 56407
[TBL] [Abstract][Full Text] [Related]
10. Immune response to a mammary adenocarcinoma. IV. Blocking of cell-mediated cytolysis by immunoglobulins binding to immune lymphocytes.
Huber SA; Lucas ZJ
J Immunol; 1977 Aug; 119(2):726-36. PubMed ID: 328781
[No Abstract] [Full Text] [Related]
11. An innate host response to the neoplastic cell: syngeneic rat tumor cells can elicit a rapid de novo lymphoid procoagulant response.
Lando PA; Edgington TS
J Immunol; 1985 Nov; 135(5):3587-95. PubMed ID: 4045197
[TBL] [Abstract][Full Text] [Related]
12. Relationship of cellular proliferation and the generation of cytotoxic cells in an in vitro secondary immune response to syngeneic rat lymphoma cells.
Bernstein ID; Cohen EF; Wright PW
J Immunol; 1977 Mar; 118(3):1090-4. PubMed ID: 845434
[TBL] [Abstract][Full Text] [Related]
13. Rat mammary adenocarcinoma 13762 expressing IFN-gamma elicits antitumor CD4+ MHC class II-restricted T cells that are cytolytic in vitro and tumoricidal in vivo.
Frey AB
J Immunol; 1995 May; 154(9):4613-22. PubMed ID: 7722313
[TBL] [Abstract][Full Text] [Related]
14. Studies on the induction and expression of T cell-mediated immunity. IV. Non-overlapping populations of alloimmune cytotoxic lymphocytes with specificity for tumor-associated antigens and transplantation antigens.
Kedar E; Bonavida B
J Immunol; 1975 Nov; 115(5):1301-8. PubMed ID: 51889
[TBL] [Abstract][Full Text] [Related]
15. Role of tumor-derived cytokines on the immune system of mice bearing a mammary adenocarcinoma. II. Down-regulation of macrophage-mediated cytotoxicity by tumor-derived granulocyte-macrophage colony-stimulating factor.
Sotomayor EM; Fu YX; Lopez-Cepero M; Herbert L; Jimenez JJ; Albarracin C; Lopez DM
J Immunol; 1991 Oct; 147(8):2816-23. PubMed ID: 1918995
[TBL] [Abstract][Full Text] [Related]
16. Generation of cytotoxic lymphocytes in vitro: response of immune rat spleen cells to a syngeneic gross virus-induced lymphoma in mixed lymphocyte-tumor culture.
Bernstein ID; Wright PW; Cohen E
J Immunol; 1976 May; 116(5):1367-72. PubMed ID: 58029
[TBL] [Abstract][Full Text] [Related]
17. Suppressor lymphokine produced by rat T-cells in response to syngeneic mammary adenocarcinoma 13762A.
Christensen ND; Kreider JW; Horetsky RL
Cancer Res; 1988 Feb; 48(4):943-9. PubMed ID: 2962735
[TBL] [Abstract][Full Text] [Related]
18. In vitro reactivity of splenic lymphocytes from normal and UV-irradiated mice against syngeneic UV-induced tumors.
Fortner GW; Kripke ML
J Immunol; 1977 Apr; 118(4):1483-7. PubMed ID: 66296
[TBL] [Abstract][Full Text] [Related]
19. Possible evidence for antibody-dependent macrophage-mediated cytotoxicity directed against murine adenocarcinoma cells in vivo.
Haskill JS; Fett JW
J Immunol; 1976 Nov; 117(5 Pt.2):1992-8. PubMed ID: 993593
[TBL] [Abstract][Full Text] [Related]
20. Evidence for involvement of B lymphocytes in the surveillance of lung metastasis in the rat.
Quan N; Zhang Z; Demetrikopoulos MK; Kitson RP; Chambers WH; Goldfarb RH; Weiss JM
Cancer Res; 1999 Mar; 59(5):1080-9. PubMed ID: 10070966
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
